We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+19.52%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$8B
AUM Growth
+$718M
Cap. Flow
-$112M
Cap. Flow %
-1.4%
Top 10 Hldgs %
32.48%
Holding
287
New
37
Increased
60
Reduced
158
Closed
30

Top Buys

Rank Stock Value
1
FWRG icon
First Watch Restaurant Group
FWRG
+$56.6M
2
TKO icon
TKO Group
TKO
+$47.8M
3
PLTR icon
Palantir
PLTR
+$43.5M
4
APPF icon
AppFolio
APPF
+$31.9M
5
ARQT icon
Arcutis Biotherapeutics
ARQT
+$31.6M

Top Sells

Rank Stock Value
1
EDR
Endeavor Group Holdings, Inc.
EDR
+$53.1M
2
DE icon
Deere & Co
DE
+$49.8M
3
NVDA icon
NVIDIA
NVDA
+$38.2M
4
CALX icon
Calix
CALX
+$33.1M
5
SNOW icon
Snowflake
SNOW
+$31.8M

Sector Composition

Rank Sector Weight
1 Technology 33.99%
2 Consumer Discretionary 18.65%
3 Healthcare 16.16%
4 Communication Services 12.62%
5 Industrials 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RUN icon
201
Sunrun
RUN
$2.02B
$1.39M 0.02%
105,191
+58,406
+125% +$803K
BRZE icon
202
Braze
BRZE
$2.92B
$1.36M 0.02%
30,642
-955
-3% -$51.6K
FIP icon
203
FTAI Infrastructure
FIP
$332M
$1.3M 0.02%
+207,415
New +$962K
PODD icon
204
Insulet
PODD
$9.64B
$1.25M 0.02%
7,314
+4,606
+170% +$859K
MKTX icon
205
MarketAxess Holdings
MKTX
$5.74B
$1.22M 0.02%
5,587
-39,148
-88% -$9.25M
STOK icon
206
Stoke Therapeutics
STOK
$1.81B
$1.21M 0.02%
89,783
+27,535
+44% +$167K
PCVX icon
207
Vaxcyte
PCVX
$8.78B
$1.17M 0.01%
17,078
-23
-0.1% -$1.59K
BHVN icon
208
Biohaven
BHVN
$1.83B
$1.13M 0.01%
20,673
-9,179
-31% -$454K
CYTK icon
209
Cytokinetics
CYTK
$9.55B
$985K 0.01%
14,051
-12,294
-47% -$951K
NEWP
210
New Pacific Metals
NEWP
$1.02B
$966K 0.01%
720,523
-325,453
-31% -$407K
COHR icon
211
Coherent
COHR
$53B
$949K 0.01%
15,656
-30
-0.2% -$1.65K
IAUX
212
i-80 Gold Corp
IAUX
$1.46B
$917K 0.01%
684,633
-18,620
-3% -$27K
AZEK
213
DELISTED
The AZEK Co
AZEK
$915K 0.01%
+18,215
New +$794K
RELY icon
214
Remitly
RELY
$4.62B
$908K 0.01%
43,804
+3,618
+9% +$68.7K
RIG icon
215
Transocean
RIG
$6.6B
$904K 0.01%
143,915
-49,304
-26% -$269K
NARI
216
DELISTED
Inari Medical, Inc. Common Stock
NARI
$882K 0.01%
+18,389
New +$982K
EVRI
217
DELISTED
Everi Holdings
EVRI
$849K 0.01%
84,429
+42,802
+103% +$443K
SANA icon
218
Sana Biotechnology
SANA
$937M
$843K 0.01%
+84,259
New +$631K
RARE icon
219
Ultragenyx Pharmaceutical
RARE
$1.29B
$813K 0.01%
17,423
-177
-1% -$8.35K
CGON icon
220
CG Oncology
CGON
$6.49B
$813K 0.01%
+18,523
New +$756K
HWM icon
221
Howmet Aerospace
HWM
$89.4B
$780K 0.01%
11,395
-142
-1% -$8.71K
ACMR icon
222
ACM Research
ACMR
$4.44B
$779K 0.01%
+26,721
New +$612K
UTI icon
223
Universal Technical Institute
UTI
$1.12B
$778K 0.01%
+48,839
New +$709K
CLH icon
224
Clean Harbors
CLH
$17B
$773K 0.01%
+3,840
New +$690K
VRTX icon
225
Vertex Pharmaceuticals
VRTX
$131B
$750K 0.01%
1,794
-20
-1% -$8.46K
7 8
9
10 11

Similar funds

Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
SC
Starlite Capital Dallas, Texas $9.7B AUM
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.8B AUM 0.07% 1-Year Est. Return
HTC
Hershey Trust Company Hershey, Pennsylvania $9.82B AUM 0.48% 1-Year Est. Return

Gilder Gagnon Howe & Co's Q1 2024 Portfolio in Review

As of Q1 2024, Gilder Gagnon Howe & Co held 287 positions worth $8B, up 9.8% from $7.29B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Gilder Gagnon Howe & Co's Q1 2024 filing shows 37 new, 60 increased, 158 reduced and 30 closed positions. Its largest new stake was TKO Group: 574,544 shares worth $49.6M. The largest sale was Endeavor Group Holdings, Inc., an estimated $53.1M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Gilder Gagnon Howe & Co's largest Q1 2024 buy was TKO Group: 574,544 shares worth $49.6M.
  • Gilder Gagnon Howe & Co added most to First Watch Restaurant Group in Q1 2024, an estimated $56.6M increase.
  • Gilder Gagnon Howe & Co's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $38.2M.
  • Gilder Gagnon Howe & Co fully exited Endeavor Group Holdings, Inc. in Q1 2024, selling an estimated $53.1M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 32% of its $8B portfolio in Q1 2024.
  • Gilder Gagnon Howe & Co opened 37 new positions and closed 30 in Q1 2024.
  • Gilder Gagnon Howe & Co's portfolio value rose 9.8% quarter-over-quarter to $8B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2024, filed 15 May 2024.